# Nab-PTX, Ifosfamide and Cisplatin in the Treatment of Pediatric Extracranial Germ Cell Tumor.

> **NCT04581265** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 43 (estimated)

## Conditions studied

- Extracranial Germ Cell Tumor, Pediatric

## Interventions

- **DRUG:** albumin-bound paclitaxel (nab-PTX), ifosfamide and cisplatin

## Key facts

- **NCT ID:** NCT04581265
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-10
- **Primary completion:** 2023-11-10
- **Final completion:** 2024-05-10
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2020-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04581265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04581265, "Nab-PTX, Ifosfamide and Cisplatin in the Treatment of Pediatric Extracranial Germ Cell Tumor.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04581265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*